Welcome to our dedicated page for Healthequity news (Ticker: HQY), a resource for investors and traders seeking the latest updates and insights on Healthequity stock.
HealthEquity, Inc. (HQY) administers health savings accounts and complementary consumer-directed benefits for employers, benefits advisors, health plans, retirement plan providers, and healthcare consumers. Company updates commonly cover HSA account growth, HSA assets, service, custodial and interchange revenue, guidance, margin measures, stock repurchases, and actions to manage HSA cash repricing exposure.
News also includes board and executive governance changes, investor conference participation, research on healthcare affordability and HSA adoption, and product or platform themes tied to helping members save, spend and invest for healthcare.
HealthEquity (NASDAQ: HQY) reported fiscal 2027 Q1 revenue of $354.6 million, up 7% year over year. Net income rose 29% to $69.4 million ($0.82 diluted EPS), and Adjusted EBITDA increased 17% to $164.5 million with a 46% margin.
HSA assets grew 19% to $37.1 billion. The board expanded the share repurchase authorization by $1.0 billion after buying $123.0 million in Q1. HealthEquity raised its fiscal 2027 outlook, guiding to revenue of $1.410–$1.420 billion and Adjusted EBITDA of $625–$633 million.
HealthEquity (NASDAQ: HQY) will release fiscal 2027 first quarter results after market close on May 28, 2026, followed by a management conference call at 4:30 p.m. ET on the same day. A replay and live webcast will be available at ir.healthequity.com.
Management will also present at investor conferences in May and June 2026, including BofA Health Care (May 12), JP Morgan (May 19), and RBC FinTech (June 9).
HealthEquity (NASDAQ: HQY) appointed William “Bill” Gassen, president and CEO of Sanford Health, to its board effective March 26, 2026. Gassen will join the Audit and Risk Committee and the Talent, Compensation and Culture Committee, expanding the board to 10 directors, eight of whom are independent.
Gassen leads the nation’s largest rural health system and brings operational and payer-provider perspective; he also serves on the board of Oscar Health (NYSE: OSCR).
HealthEquity (NASDAQ: HQY) reported record fiscal 2026 results, including net income $215.2M (+123% YoY), Adjusted EBITDA $566.0M (+20%), and Total HSA Assets $36.5B (+14%). The company added 1.0M new HSAs from sales, repurchased $301.7M of stock, and hedged $2.35B of HSA cash risk. Management raised fiscal 2027 guidance: revenue $1.405B–$1.415B, net income $239M–$246M, non-GAAP net income $392M–$400M, and Adjusted EBITDA $618M–$628M.
Phreesia (NYSE: PHR) appointed Jon Kessler to its Board, effective April 6, 2026, while directors Edward L. Cahill and Michael Weintraub will retire at the 2026 Annual Meeting. The Board will reduce to seven members and a new chair will be named after Weintraub's retirement.
Since the 2019 IPO, revenue grew from about $100 million to over $460 million for the twelve months ended October 31, 2025, and Phreesia enabled roughly 170 million patient visits in 2024.
HealthEquity (NASDAQ: HQY) reported record fourth-quarter sales and strong fiscal 2026 metrics. HSAs reached 10.6 million (+7%), Total Accounts 17.8 million (+4%), HSA Assets $36.5B (+14%) and HSA investments $18.5B (+26%).
The company reaffirmed fiscal 2026 guidance (near top of prior ranges) and will provide updated fiscal 2027 guidance with March results. Management set its Q4/fiscal 2026 earnings call for March 17, 2026.
HealthEquity (NASDAQ: HQY) provided its initial fiscal 2027 outlook and will present the details at the J.P. Morgan Healthcare Conference on Jan 13, 2026 at 3:00 pm PT. Management expects FY2027 revenue of $1.38B–$1.41B, Adjusted EBITDA margin of 43.8%–44.3%, and a yield on HSA Cash of ~3.75%. The company also reaffirmed previously provided guidance for fiscal 2026. Executives presenting include CEO Scott Cutler, Vice Chair and Founder Steve Neeleman, and EVP/CFO James Lucania. A live audio webcast and presentation slides will be available and archived on the company investor relations website.
HealthEquity (NASDAQ: HQY) released its inaugural Fall 2025 Healthcare Affordability Pulse surveying 618 employed Americans between June 25 and July 9, 2025. The results show a generational divide: 56% of Gen Z and 50% of Millennials have HSAs versus 35% Gen X and 24% Boomers. Younger workers report higher benefits understanding (Gen Z 53%, Millennials 62%) but greater economic anxiety (Gen Z 84%) and workplace distraction from finances. HSA holders generally show stronger preparedness for routine care (52% vs 46%), larger emergency reserves (29% with ≥$5,000 vs 25%), and are less likely to cut critical care. HealthEquity links education and employer support to improved financial wellbeing.
HealthEquity (NASDAQ: HQY) reported third-quarter fiscal 2026 results for the period ended October 31, 2025, with revenue of $322.2 million (up 7% year‑over‑year) and net income of $51.7 million ($0.59 per diluted share).
Key operating metrics: Adjusted EBITDA $141.8 million (44% of revenue, +20% YoY), non‑GAAP net income per diluted share $1.01 (+29% YoY), 10.1 million HSAs (+6% YoY) and Total HSA Assets $34.4 billion (+15% YoY). The company repurchased 1.0 million shares for $93.7 million and maintains $258.8 million remaining repurchase authorization. FY26 guidance: revenue $1.302B–$1.312B; non‑GAAP net income per share $3.87–$3.95.
HealthEquity (Nasdaq: HQY) announced it will deploy agentic AI built with Parloa to deliver conversational, action‑oriented member support across voice, mobile app chat, and web starting with a limited release in November 2025 and expanding through 2026. The system preserves context across turns, blends automated actions with human escalation, and builds on existing AI tools including an Expedited Claims AI that saves members an average of 70% of claims-entry time with more than half processed in under two minutes, plus HSAnswers and HealthEquity Assist™ suites. HealthEquity positions the rollout as a phased, measured deployment to refine member experience before full scale.